National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Ocriplasmin (Jetrea®) is a hospital only product licensed in adults for the treatment of vitreomacular traction (VMT), including when associated with macular hole of diameter less than or equal to 400 microns.

 Rapid Review

Commenced Completed Outcome
12/06/2013 09/07/2013 Full Pharmacoeconomic Evaluation not Recommended